TOMA Biosciences

📍 Foster City, United States🗓 Founded 2011👥 10 employees💰 Last funded Jan 2014
Biotechnology🌐 tomabio.com
Website LinkedIn
Cancer is not an anatomical disease; it is fundamentally a disease of the genome within cancer cells. TOMA technology enables laboratories to uncover the DNA alterations in cancer cells to provide meaningful data for researchers and clinicians seeking the optimal treatment options for their patients. In a recent study (http://meetinglibrary.asco.org/content/152750-156) conducted by Intermountain Healthcare using TOMA reagent kits, cancer genomic testing nearly doubled the progression free survival of patients with advanced cancer. TOMA OS-Seq™ technology enables comprehensive analysis of every alteration type from all types of clinical tumor samples. Our reagents and methods amplify only the targets of interest instead of the whole genome, significantly speeding up the library preparation to less than 8 hours. TOMA kits can also be run on your current NGS platform. We offer a fast, simple and efficient way to generate reliable and clinically meaningful sequencing data. For more information, please contact us today. (www.tomabio.com)
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in TOMA Biosciences?
TOMA Biosciences has 2 investors on record on gritt.io, 2 mid-stage.
When did TOMA Biosciences last raise funding?
The most recent investment in TOMA Biosciences recorded on gritt.io was in January 2014.
When was TOMA Biosciences founded?
TOMA Biosciences was founded in 2011.
What industry is TOMA Biosciences in?
TOMA Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is TOMA Biosciences based?
TOMA Biosciences is headquartered in Foster City, United States.